The LIVER formula is used a lot to help diabetes patients with LIVER and GASTRIC problems. It can also help various diseases as below:
Anti-ulcer: In lab tests, the formula can prevent gastric ulcers from various chemical damages in test animals, P<0.05 or P<0.01. It could reduce the MAO (maximum acid output) and total gastric juice, while increasing the protection strength of gastric mucus and wall. In three clinical reports, 97 CAG (chronic atrophric gastritis) patients taking the formula up to three months, the results were: 33 cured (34.02%), 24 significantly improved (24.74%), 33 improved (34.02%) and only 7 patients did not improve (7.22%). Of 18 another gastric ulcer patients taking it for three months, only 3 did not improve; the other 15 were either cured or improved.
Liver disease: Seven reports on 533 patients with various liver diseases, taking the formula from two to 15 months found 94 cured (17.64%), 91 significantly improved (17.07%), 300 improved (56.29%) and 48 did not improve (9.01%). A report on 129 positive HBsAg patients, divided into a treatment group taking it for up to two months(n=83) and a comparison group (n=46) taking regular western medicine for the same period of time showed the following results: HBsAg turned negative: 44 vs. 6 (53.01% vs. 13.04%), P<0.001. Total effective rate was 91.6% vs. 36.9%, P<0.01. Another 36 hepatitis B patients took the formula and its modifications from one to three months, and 29 were cured (80,55%), 5 improved (13.89%) and only two patients (5.56%) did not improve.
Central retinaitis: 45 patients taking the formula for the average of two months and 35 were cured (77.77%), 8 improved (17.78%) and 2 did not improve (4.44%).
PMS: Of 36 females, from 25 to 40 years old all having been treated with regular western medicine to little effects, 26 (72.2%) significantly improved and 10 (27.8%) were improved after taking the formula.
Herpes: Of 336 patients using the formula for two weeks, 318 were cured (94.64%) and 18 significantly improved (5.36%). A report on 100 patients who were divided into a treatment group (n=58) and a comparison group (n=42) using Vit. B 100 mg IV injections and Vit. B.12 at 200ug showed: Cured: 56 vs. 30 (96.55% vs. 71.42%), improved: 2 vs. 5 (3.45% vs. 11.90%) and 7 cases in comparison group did not improve ( 0% vs. 16.67%). There is a significant difference between two groups.
Ingredent: Patent pending, available upon request.
Toxicity and side effects: There is no death after 72 hours at the dosage of 40g/Kg and 50g/Kg. The LD50 can not be measured. There is no known toxicity or side effects to the formula.
